Guangzhou Tonglin Jewelry Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Tonglin Jewelry Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include ELSPETH, JALOKIVI, and SILVERNANA. The owner is based in Guangzhou.

504-272, Building 19, No. 644

Shibei Gongye Rd, Dashi St, Panyu Dist

Guangzhou 510000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELSPETH
ELSPETH
Registered 2022
JALOKIVI
JALOKIVI
Registered 2022

Trademark Classifications

Guangzhou Tonglin Jewelry Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (3 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Guangzhou Tonglin Jewelry Co., Ltd. have?

Guangzhou Tonglin Jewelry Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Guangzhou Tonglin Jewelry Co., Ltd. file in?

Guangzhou Tonglin Jewelry Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Guangzhou Tonglin Jewelry Co., Ltd.'s most well-known trademarks?

Guangzhou Tonglin Jewelry Co., Ltd.'s registered trademark portfolio includes well-known marks such as ELSPETH, JALOKIVI, and SILVERNANA. These are among 3 currently registered trademarks in the portfolio.

What is Guangzhou Tonglin Jewelry Co., Ltd.'s trademark registration success rate?

Guangzhou Tonglin Jewelry Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.